Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21474646 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
BUILD 3: Bosentan Use in Interstitial Lung Disease
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: placebo;   Drug: Bosentan

Indicates status has not been verified in more than two years